Few years ago our friend Dr. Kalyan Handique established a startup nanotechnology company called Handylab in Ann Arbor , Michigan after completing his doctorate degree (Ph.D.) in Chemical engineering from University of Michigan.
I am very happy to give you the good news that it was announced in late October that Handylab was acquired for approximately 300 million dollars by the multi-billion dollar Medical device company Becton, Dickinson and Company (BD) of New Jersey.
This transaction is a great validation for the technology, products and the efforts of each and every person that contributed to HandyLab. Kalyan’s entrepreneurship may encourage our younger generation to follow the footsteps of Kalyan.
BD, the multi-billion dollar Medical Device Company has signed a definitive agreement to acquire HandyLab to help enhance its molecular diagnostics business. Michigan-based HandyLab develops and manufactures molecular diagnostic assays and automated platforms that make molecular testing more efficient and cost effective. The acquisition grew out of a development and distribution agreement the two companies forged earlier this year in order to address the growing Hospital Acquired Infection market and other segments of molecular diagnostics. This deal will accelerate the deployment of HandyLab’s leading molecular diagnostic platform all across the globe. HandyLab will operate as a subsidiary of BD in Ann Arbor.
Satyen Das, Washington, DC